A detailed history of Black Rock Inc. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,095,894 shares of XENE stock, worth $80.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,095,894
Previous 2,121,928 1.23%
Holding current value
$80.3 Million
Previous $91.3 Million 10.54%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$36.25 - $43.75 $943,732 - $1.14 Million
-26,034 Reduced 1.23%
2,095,894 $81.7 Million
Q1 2024

May 10, 2024

BUY
$42.66 - $50.04 $2.34 Million - $2.75 Million
54,865 Added 2.65%
2,121,928 $91.3 Million
Q4 2023

Feb 13, 2024

BUY
$28.7 - $46.46 $30.9 Million - $50 Million
1,075,606 Added 108.49%
2,067,063 $95.2 Million
Q3 2023

Nov 13, 2023

SELL
$34.16 - $39.73 $88,235 - $102,622
-2,583 Reduced 0.26%
991,457 $33.9 Million
Q2 2023

Aug 11, 2023

BUY
$34.84 - $43.54 $3.31 Million - $4.13 Million
94,886 Added 10.55%
994,040 $38.3 Million
Q1 2023

May 12, 2023

SELL
$33.46 - $40.35 $885,652 - $1.07 Million
-26,469 Reduced 2.86%
899,154 $32.2 Million
Q4 2022

Feb 13, 2023

SELL
$33.06 - $39.43 $3.86 Million - $4.61 Million
-116,906 Reduced 11.21%
925,623 $36.5 Million
Q3 2022

Nov 14, 2022

BUY
$30.79 - $39.82 $5.36 Million - $6.94 Million
174,239 Added 20.07%
1,042,529 $37.6 Million
Q2 2022

Aug 12, 2022

BUY
$25.44 - $35.16 $6.44 Million - $8.91 Million
253,333 Added 41.2%
868,290 $26.4 Million
Q1 2022

May 12, 2022

BUY
$25.09 - $33.13 $1.19 Million - $1.57 Million
47,385 Added 8.35%
614,957 $18.8 Million
Q4 2021

Feb 10, 2022

BUY
$15.6 - $35.4 $1.94 Million - $4.41 Million
124,520 Added 28.11%
567,572 $17.7 Million
Q3 2021

Nov 09, 2021

BUY
$14.86 - $19.45 $472,548 - $618,510
31,800 Added 7.73%
443,052 $6.77 Million
Q2 2021

Aug 11, 2021

BUY
$16.81 - $20.0 $6.91 Million - $8.23 Million
411,252 New
411,252 $7.66 Million

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.39B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.